Clinical Trial Update: ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission [Phase 3]

View source ↗

Summary

Phase 3 trial update on AOP2014 assessing efficacy and safety in chronic myeloid leukemia in remission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia in Remission

Drugs mentioned

• AOP2014

Snippet

Sponsor: Philipps University Marburg | Conditions: Chronic Myeloid Leukemia in Remission | Phase 3 | Status: COMPLETED